This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
Stroke Early Supported Discharge (ESD) is a multidisciplinary team intervention that clinical trials have shown reduces length of hospital stay and reduces risk of death and dependency. This research programme will investigate the impact of implementing ESD at scale and in real world conditions and investigate which models of ESD are effective in practice.
In this study we are testing the theory that by treating BP more intensively we will delay progression of the disease. We will also use state-of-the-art MRI imaging techniques to look at the mechanisms by which any beneficial effect of BP occurs.
The ReTrain study is investigating the effectiveness of a community-based rehabilitation training programme for people who have suffered a stroke. Published in the journal BMJ Open, the 'study protocol' for ReTrain outlines why the study was needed, and includes the methods to be used in the study, the resources required for the study and a timeline for completion.
Visual field loss is a commonly reported side effect of stroke and can seriously impact on functional ability and quality of life. Published today in the journal, Neuro-Ophthalmology, a new study shares insights learned from recruitment of study participants to the 'VISION' trial, and how this may inform future, similar trials.
The International Stroke Conference (ISC) is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take homes from our International Development Officer, Sarah Belson.
Medical research is essential to develop new treatments and therapies for stroke so that patients in the UK can get the best possible care. Clinical trials are conducted to test whether a new medical intervention is safe and effective and these trials often rely on the participation of volunteer stroke survivors.
Apathy has a major effect of quality of life for a SVD sufferer; we have shown that for the patient it is more important in determining quality of life than is disability, such as weakness, from the stroke itself.
This study will compare tenecteplase, a newer clot-busting drug, with alteplase, which is currently the routine treatment used in hospitals.
This research is testing whether starting ‘active’ rehabilitation in hospital within 24 hours of stroke will lead to better recovery after stroke than traditional methods.